Non-Qualified Stock Option (right to buy)

Common Stock

The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled.

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.


Reflects the weighted average price of 1,725 shares of common stock of Proto Labs Inc. purchased by the reporting person in multiple transactions on August 4, 2025 with purchase prices ranging from $43.47 to $43.53 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.


The transaction reported is a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. One-third of the units granted vest on each of the first three anniversaries of the date of the grant. Units are subject to forfeiture until vested.

Includes 136,435 unvested restricted stock units with each unit representing the contingent right to receive one share of the Issuer's common stock upon vesting.


Glabe Scott

C/O TRUMP MEDIA & TECHNOLOGY GROUP CORP.

Common Stock, par value $0.0001 per share

The securities reported are restricted stock units ("RSUs"), each of which represents the contingent right to receive one share of Trump Media & Technology Group Corp.'s (the "Issuer") common stock, par value $0.0001 per share (the "common stock"). Subject to the terms and conditions of the RSU award and the Issuer's 2024 Amended & Restated Equity Incentive Plan, the RSU award will vest in three (3) substantially equal annual installments and will be fully vested as of May 22, 2028.

Certain of the securities reported in Column 5 of Table I are RSUs. Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's Amended and Restated 2024 Equity Incentive Plan.

Reflects a transaction solely to cover the Issuer's withholding payments to applicable taxing authorities. No cash proceeds were received by the reporting person in connection with the disposition of securities disclosed in this row.

The price reported in Column 4 is a weighted average price. These shares were disposed of in multiple transactions at prices ranging from $15.985 to $16.460, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed of at each separate price within the range.

/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact


Sales made pursuant to a 10(b)5-1 trading plan previously adopted by the Reporting Person on December 13, 2024.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $311.30 to $312.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $312.46 to $313.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $313.48 to $313.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $312.15 to $312.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $313.15 to $313.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $312.14 to $313.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These Class A Shares are held by a pension trust of which the Reporting Person is the sole trustee and who, in that capacity, possesses sole voting and sole dispositive power over these Class A Shares. However, the Reporting Person does not possess any pecuniary interest in these Class A Shares.

These Class A Shares are owned by IGSB Cardinal I, LLC, a limited liability company, of which the Reporting Person is the managing member.  In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares. However, the Reporting Person disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

These Class A Shares are owned by IGSB Gaucho Fund I, LLC, a limited liability company, of which the Reporting Person is the managing member. In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares. However, the Reporting Person disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

These Class A Shares are owned by IGSB Cardinal Core BV, LLC, a limited liability company, of which the Reporting Person is the managing member. In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares, but he disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

/s/ Kimberly Shea, Attorney-in-Fact for Maurice J. Duca


The price reported in Column 4 is a weighted average price. These shares were disposed of in multiple transactions at prices ranging from $15.975 to $16.460, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed of at each separate price within the range.


The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.


The securities reported are restricted stock units ("RSUs"), each of which represents the contingent right to receive one share of Trump Media & Technology Group Corp.'s (the "Issuer") common stock, par value $0.0001 per share (the "common stock"). Subject to the terms and conditions of the RSU award and the Issuer's 2024 Amended & Restated Equity Incentive Plan, the RSU award will vest in three (3) substantially equal annual installments and will be fully vested as of May 22, 2028.

Certain of the securities reported in Column 5 of Table I are RSUs. Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's Amended and Restated 2024 Equity Incentive Plan.

Reflects a transaction solely to cover the Issuer's withholding payments to applicable taxing authorities. No cash proceeds were received by the reporting person in connection with the disposition of securities disclosed in this row.

The price reported in Column 4 is a weighted average price. These shares were disposed of in multiple transactions at prices ranging from $15.980 to $16.460, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed of at each separate price within the range.


Through Blair Jordan Strategy and Finance Consulting Inc.

Common Stock

Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity.

On February 5, 2025, the Issuer, the Reporting Person and Dr. James Woody, entered into a Voting Agreement, whereby Dr. Woody agreed to vote a total of 43,166 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to February 5, 2026, the date after August 5, 2025, that Dr. Woody has sold all of the shares or the date that the Issuer terminates the Voting Agreement. In order to enforce the terms of the Voting Agreement, Dr. Woody provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 43,166 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 43,166 shares of common stock of the Issuer held by Dr. Woody. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

On February 21, 2025, the Issuer, the Reporting Person and Dr. Marlene Krauss, entered into a Voting Agreement, whereby Dr. Krauss agreed to vote a total of 200,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of the Voting Agreement, Dr. Krauss provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 200,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 200,000 shares of common stock of the Issuer held by Dr. Krauss. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

On April 28, 2025, the Issuer, the Reporting Person and Elray Resources, Inc. ("Elray") entered into a Voting Agreement, whereby Elray agreed to vote a total of 1,318,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to April 28, 2026. In order to enforce the terms of the Voting Agreement, Elray provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 1,318,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 1,318,000 shares of common stock of the Issuer held by Elray. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

The options were granted under the 2025 Supplemental Option Plan of the Issuer. The options vested immediately, but were not exercisable until or unless the closing of the transactions contemplated by the July 29, 2025, Securities Purchase Agreement between the Issuer and the purchasers set forth therein occurred, which closing date was August 4, 2025. Separately, the options are not exercisable until stockholder approval of the 2025 Plan is received. If stockholder approval is not received prior to July 29, 2026, the options will be cancelled.

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as an officer of the Issuer.


Common Stock

Represents the number of shares earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 1, 2026, subject to the Reporting Person continuing to provide service to the Company through such vesting date.

/s/ Cristin Rothfuss, as Attorney-in-Fact for Bilal Arif


Common Stock

/s/ Cristin Rothfuss, as Attorney-in-Fact for Ian Michael Estepan


This transaction for the sale of 250 units at a price of $45.00 per unit was made pursuant to a 10b5-1 plan adopted on March 6, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).


Common Stock

/s/ Cristin Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac


This transaction was executed in a single trade at the stated price.


The securities were purchased through the Issuer's Market Price Stock Purchase Plan effective May 13, 2023. The purchase was approved by the Company's Board of Directors on August 5, 2025.


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $37.00 to $37.67 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Each Dividend Equivalent Unit (DEU) represents a contingent right to receive one ordinary share of FDP.  DEUs are subject to the same restrictions and vesting and/or performance criteria based on the underlying Restricted Stock Units (RSUs) and/or Performance Stock Units (PSUs) to which they relate.

Includes 5,517.5877 shares acquired through a dividend reinvestment plan.

The RSUs convert to Ordinary Shares on a one-for-one basis.

The RSUs were awarded on 3/2/2023 and vest in three equal installments over three years. The remaining vesting will occur on 3/2/2026.

The RSUs were awarded on 3/3/2025 and will vest in three equal installments over three years. The vestings will occur on 3/3/2026, 3/3/2027 and 3/3/2028.

The PSUs convert to Ordinary Shares on a one-to-one basis.

These PSUs were awarded on 3/1/2024 subject to meeting the minimum performance criteria which was met at 105.5%. The PSUs vest in three equal annual installments. The remaining vestings will occur on 3/1/2026 and 3/1/2027.

The PSUs were awarded on 3/3/2025 and are earned subject to meeting minimum performance criteria.  Once earned, the PSUs vest in three equal annual installments on each of 3/3/2026, 3/3/2027 and 3/3/2028.

/s/ Effie D. Silva, Attorney-in-Fact for Mohammad Abu-Ghazaleh


Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

Includes 0.020776 Ordinary Shares acquired through a dividend reinvestment plan, which is exempt under Rule 16a-11.

Each Dividend Equivalent Unit ("DEU") represents a contingent right to receive one ordinary share of FDP. DEUs are subject to the same restrictions and vesting and/or performance criteria based on the underlying Restricted Stock Units ("RSUs") and/or Performance Stock Units ("PSUs") to which they relate.

Includes 471.2805 shares acquired through a dividend reinvestment plan.

The RSUs were awarded on 3/2/2023 and vest in three equal installments over three years. The remaining vestings will occur on 3/2/2026.

The RSUs were awarded on 3/3/2025 and vest in three equal installments over three years. The vestings will occur on each of 3/3/2026, 3/3/2027 and 3/3/2028.

The PSUs convert to Ordinary Shares on a one-for-one basis.

The PSUs were awarded on 3/1/2024 subject to meeting minimum performance criteria which was met at 100%. The PSUs vest in three equal annual installments,  The remaining vestings will occur on 3/1/2026 and 3/1/2027.


Includes 8,760 shares owned in the Riverview 401(k) Plan.


This Form 4 is filed on behalf of GoldenTree Asset Management LP (the "Advisor"), GoldenTree Asset Management LLC (the "General Partner") and Steven A. Tananbaum (collectively, the "Reporting Persons"). The Advisor is the investment manager or advisor to certain funds and separate accounts managed by the Advisor (the "Funds") and may be deemed to have a pecuniary interest in the securities directly held by the Funds. The General Partner is the general partner of the Advisor and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor has a pecuniary interest. Steven A. Tananbaum is the managing member of the General Partner and may be deemed to have a pecuniary interest in the Ordinary Shares reported herein in which the Advisor and the General Partner have a pecuniary interest.

The Advisor, the General Partner, and Mr. Tananbaum disclaim beneficial ownership of the Ordinary Shares held by the Funds.

The securities reported herein include 7,926,176 Ordinary Shares held directly by certain funds and separate accounts managed by the Advisor and 20,000 Ordinary Shares held directly by Mr. Tananbaum.


Represents a grant of restricted common stock to a corporation owned by the Reporting Person as compensation for the Reporting Person's past performance.


Common Stock, par value $0.001 per share

This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.63 to $160.175 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.005 to $157.425 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 136,167 shares of common stock and 38,573 restricted stock units. Each restricted stock unit represents the right to receive, upon vesting, one share of common stock. 11,556 restricted stock units will vest on March 14, 2026, 15,194 restricted stock units will vest evenly over two years on March 19, 2026 and March 19, 2027 and 11,823 restricted stock units will vest evenly over three years on March 12, 2026, March 12, 2027 and March 12, 2028. All such vests assume continued employment through the applicable vest date.

All such options are presently exercisable.

/s/ Brandon F. Lombardi, Attorney-in-Fact for Jack L. Sinclair


Includes 13,054 shares of common stock and 1,940 restricted stock units. Each restricted stock unit represents the right to receive, upon vesting, one share of common stock. These restricted stock
units will vest on March 12, 2026, assuming continued service through such vest date.

/s/ Brandon F. Lombardi, Attorney-in-Fact for Joseph D. O'Leary


Common Stock

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date).


The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for any purpose.


Common Stock

Performance Based Restricted Stock Units

Common Stock

On August 4, 2025, as a result of the mergers contemplated by that certain Agreement and Plan of Merger, dated as of May 14, 2025, by and among the Issuer, NV5 Global, Inc. ("NV5"), Ryder Merger Sub I and Ryder Merger Sub II (the "Merger Agreement"), 13,328 shares of common stock of NV5 and 157,716 restricted stock awards of NV5 (which were vested in full in accordance with their terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings)were converted into the right to receive 1.1523 shares of the Issuer's common stock ("Common Stock") per share, and $10.00 in cash per share, without interest (collectively, the "Merger Consideration"). Pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers.

These restricted stock units vest on September 30, 2028.

Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

These performance restricted stock units vest upon certain financial performance metrics of NV5 and to the extent earned will vest on September 30, 2026. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.


The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $174.620 to $175.515. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $175.875 to $176.615. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $176.635 to $177.615. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $177.625 to $178.615. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $178.635 to $179.615. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $179.625 to $179.935. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

/s/ Rebecca Peters, Attorney-in-Fact for Colette Kress


Wright Family Trust dated December 12, 1990

The Lauren Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT

The Lauren Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT

The Lauren Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT

The Stephanie Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT

The Stephanie Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT

The Stephanie Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT

The Stephanie Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT

The Lauren Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT

Common Stock

Dickerson Wright and his wife, Katherine Wright, are trustees. As a trustee, the Reporting Person may be deemed to exercise voting and investment power over the shares held by each trust. Mr. Wright disclaims beneficial ownership of these securities except to the extent of this pecuniary interest therein.


The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $3.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Represents shares held by the Siegel Family Trust, of which the Reporting Person and Rochelle Siegel are co-trustees.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.765 to $3.875 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.725 to $3.865 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

/s/ Ryan Sakamoto, Attorney-in-Fact for Reporting Person


The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.78 to $3.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

These shares are held of record by the Yarbrough Family Trust dated March 23, 2017, a living trust, of which the Reporting Person is co-trustee.


By Olivan Reinhold Family Revocable Trust u/a/d 10/16/12

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2024.

Shares held of record by the reporting person, manager of Olivan D LLC.

Shares held of record by the reporting person and his spouse, managers of Olivan Reinhold D LLC.

Shares held of record by the reporting person's spouse, manager of Reinhold D LLC.

Shares held of record by the reporting person and his spouse, Co-Trustees of the Olivan Reinhold Family Revocable Trust u/a/d 10/16/12.

/s/ Erin Guldiken, attorney-in-fact for Javier Olivan


Class A Common Stock

Class A Common Stock

Reflects the conversion of Class A Common Units ("Class A Units") of Carvana Group, LLC ("Carvana Group") owned directly by Ernest C. Garcia II into shares of Class A Common Stock ("Class A Shares") of the Issuer pursuant to the Exchange Agreement, dated April 27, 2017, by and among the Issuer, Carvana Co. Sub LLC, Carvana Group and the members of Carvana Group (the "Exchange Agreement").

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ernest C. Garcia II and Elizabeth Joanne Garcia on December 13, 2024.

The prices reported in Column 4 are weighted average prices.  These shares were sold in multiple transactions at prices ranging from $346.28-$347.26, inclusive (weighted average of $346.8938); $347.28-$348.27, inclusive (weighted average of $347.8007); $348.285-$349.275, inclusive (weighted average of $348.7958); $349.29-$350.26, inclusive (weighted average of $349.5925); $350.29-$351.255, inclusive (weighted average of $350.6974); $351.30-$352.29, inclusive (weighted average of $351.6709); $352.30-$353.225, inclusive (weighted average of $352.7695); $353.36-$354.31, inclusive (weighted average of $353.7458); $354.37-$355.285, inclusive (weighted average of $355.0008); $355.39-$356.365, inclusive (weighted average of $355.8493); and $356.41-$357.375, inclusive (weighted average of $356.8242), respectively.

The prices reported in Column 4 are weighted average prices.  These shares were sold in multiple transactions at prices ranging from $357.46-$358.355, inclusive (weighted average of $357.7972); $358.98-$358.99, inclusive (weighted average of $358.9867); $360.68-$361.335, inclusive (weighted average of $361.0497); $361.785-$362.665, inclusive (weighted average of $362.2238); $363.195-$364.17, inclusive (weighted average of $363.7618); $364.20-$365.18, inclusive (weighted average of $364.5407); $365.25-$366.24, inclusive (weighted average of $365.7908); $366.25-$367.215, inclusive (weighted average of $366.6938); $367.29-$368.285, inclusive (weighted average of $367.8985); and $368.31-$369.16, inclusive (weighted average of $368.6178), respectively. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Reflects the cancellation for no consideration of Class B Common Stock of the Issuer ("Class B Shares") in connection with the conversion of Class A Units into Class A Shares. Following the reported transaction, the remaining Class B Shares are owned directly by Ernest C. Garcia II.

These Class B Shares are owned directly by ECG II SPE, LLC ("E-SPE"), an entity which Mr. Garcia wholly owns and controls.

These Class A Units are owned directly by E-SPE and are exchangeable for 0.8 Class A Shares pursuant to the Exchange Agreement.


Common Stock

Common Stock

Reflects restricted stock units (RSUs) that following vesting, settled in shares of Netflix common stock on a one-for-one basis.

Shares withheld to satisfy tax withholding obligations arising out of the vesting of RSUs.

Each restricted stock unit (RSU) represents a contingent right to receive one share of Netflix common stock.

On April 28, 2025, the Reporting Person was granted 3,791 RSUs. Subject to the terms and conditions of the underlying award agreements, 1/12th of the RSUs will vest on a quarterly basis beginning on May 3, 2025 (or, to the extent it is not a trading day, the first trading day thereafter).

On April 28, 2025, the Reporting Person was granted 1,611 RSUs. Subject to the terms and conditions of the underlying award agreements, 1/11th of the RSUs will vest on a quarterly basis beginning on May 3, 2025 (or, to the extent it is not a trading day, the first
trading day thereafter).

By: Veronique Bourdeau, Authorized Signatory For: Cletus R Willems


Class A Common Stock

Class A Common Stock

The prices reported in Column 4 are weighted average prices.  These shares were sold in multiple transactions at prices ranging from $353.165-$354.135, inclusive (weighted average of $353.8135); $354.21-$355.195, inclusive (weighted average of $354.8343); $355.22-$356.19, inclusive (weighted average of $355.8348); $356.23-$357.20, inclusive (weighted average of $356.7259); $357.29-$358.21, inclusive (weighted average of $357.8762); $358.34-$359.30, inclusive (weighted average of $358.9376); $359.53-$360.40, inclusive (weighted average of $359.8848); $360.89-$361.86, inclusive (weighted average of $361.4543); $361.92-$362.89, inclusive (weighted average of $362.4047); and $362.93-$363.925, inclusive (weighted average of $363.3738), respectively. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The prices reported in Column 4 are weighted average prices.  These shares were sold in multiple transactions at prices ranging from $363.94-$364.93, inclusive (weighted average of $364.3765); $364.94-$365.86, inclusive (weighted average of $365.2579); $365.99-$366.93, inclusive (weighted average of $366.3906); $367.315-$368.13, inclusive (weighted average of $367.7711); $368.44-$369.43, inclusive (weighted average of $368.9807); $369.53-$370.525, inclusive (weighted average of $370.00); and $370.57-$371.06, inclusive (weighted average of $370.7784), respectively. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.


Common Stock

Common Stock

Each RSU represents a contingent right to receive one share of Netflix common stock.

On January 25, 2024, the Reporting Person was granted 6,524 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2024 (or, to the extent it is not a trading day, the first trading day thereafter).

On January 23, 2025, the Reporting Person was granted 3,634 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2025 (or, to the extent it is not a trading day, the first trading day thereafter).

By: Veronique Bourdeau, Authorized Signatory For: David A. Hyman


Common Stock

Common Stock

On January 25, 2024, the Reporting Person was granted 10,538 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2024 (or, to the extent it is not a trading day, the first trading day thereafter).

On January 23, 2025, the Reporting Person was granted 5,870 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2025 (or, to the extent it is not a trading day, the first trading day thereafter).

By: Veronique Bourdeau, Authorized Signatory For: Spencer Neumann


Common Stock

Common Stock

This transaction was executed in multiple trades at prices ranging from $1,157.435 to $1,157.4351. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

On January 25, 2024, the Reporting Person was granted 31,112 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2024 (or, to the extent it is not a trading day, the first trading day thereafter).

On January 23, 2025, the Reporting Person was granted 17,330 RSUs. Subject to the terms and conditions of the underlying award agreement, 1/12th of the RSUs vest on a quarterly basis beginning on February 3, 2025 (or, to the extent it is not a trading day, the first trading day thereafter).

By: Veronique Bourdeau, Authorized Signatory For: Gregory K. Peters


Common Stock

Common Stock

This transaction was executed in multiple trades at prices ranging from $1,160.40 to $1161.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

By: Veronique Bourdeau, Authorized Signatory For: Theodore A. Sarandos


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.

Represents the weighted average share price of an aggregate total of 6,630 shares sold in the price range of $23.095 to $23.79, inclusive, by the Reporting Person. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.

The shares reported include unvested restricted stock units.


The reporting person was granted restricted stock units that convert to common stock on a 1-to-1 ratio where 80% vest 33 1/3% on each anniversary of the grant date and 20% vest 33 1/3% on each anniversary of the grant date subject to meeting a performance requirement. These restricted stock units represent the portion of the grant (80%) not subject to a performance requirement.


Represents a restricted stock award granted under the Heritage Commerce Corp 2023 Equity Incentive Plan. The award vests in equal annual installments over 3 years with the first installment vesting on August 5, 2026, subject to the reporting person's continued service with the issuer through each vesting date.


Common Stock

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.00 to $13.15, inclusive. The Reporting Person undertakes to provide Lindblad Expeditions Holdings, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Stock option granted under the 2021 Long Term Incentive Plan pursuant to his employment agreement.

/s/ John J. Wolfel, Attorney-in-Fact for Benjamin Bressler


Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 6, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.5 to $42.83 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.

By: Patrick R. O'Neil, attorney-in-fact For: Richard S. Geary


Asure Software, Inc. Common Stock ($0.01 par value)

The price in column 4 is the weighted average price for the entire number of shares purchased. These shares were purchased in multiple transactions at prices ranging from $8.12 to $8.20. The Reporting Person undertakes to provide Asure Software, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.


The price in column 4 is the weighted average price for the entire number of shares purchased. These shares were purchased in multiple transactions at prices ranging from $8.19 to $8.44. The Reporting Person undertakes to provide Asure Software, Inc., any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.


Common Stock


Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.


Granted by Issuer in consideration of service as a director.

/s/ Steven R. Barth, Attorney-in-Fact for Paul Adam Leff


The Lauren Wright GST Non-ExemptTrust C/U Dickerson Wright 2010 GRAT

Dickerson Wright and his wife, Katherine Wright, are trustees. Mr. Wright disclaims beneficial ownership of these securities except to the extent of this pecuniary interest therein.

On August 7, 2024, 309,132 shares beneficially owned by The Lauren Wright Trust UAD the Dickerson Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 148,334 was transferred to The Lauren Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Lauren Wright Trust UAD the Katherine Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 204,840 was transferred to The Lauren Wright GST Exempt Trust C/U Katherine Wright
2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Lauren Wright Trust UAD the Katherine Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 104,292 was transferred to The Lauren Wright GST Non-Exempt Trust C/U Katherine
Wright 2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Stephanie Wright Trust UAD the Dickerson Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 148,334 was transferred to The Stephanie Wright GST Exempt Trust C/U Dickerson Wright 2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Stephanie Wright Trust UAD the Dickerson Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 160,798 was transferred to The Stephanie Wright GST Non-Exempt Trust C/U Dickerson Wright 2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Stephanie Wright Trust UAD the Katherine Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 204,840 was transferred to The Stephanie Wright GST Exempt Trust C/U Katherine Wright 2010 GRAT.

On August 7, 2024, 309,132 shares beneficially owned by The Stephanie Wright Trust UAD the Katherine Wright 2010 GRAT dated June 28, 2010, were broken down into two trusts for generation skipping tax planning purposes, out of which 104,292 was transferred to The Stephanie Wright GST Non-Exempt Trust C/U Katherine Wright 2010 GRAT.


NV5 Global, Inc.'s, Board of Directors authorized a 4-for-1 stock split of its common stock, effective on a split-adjusted basis on October 11, 2024. The securities beneficially owned following this reported transaction accounts for this 4-for-1 stock split.

Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock units of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.


Represents shares of the Issuer's common stock sold to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs pursuant to provisions of a restricted stock unit agreement by and between the Issuer and the Reporting Person.

/s/ Jongmin Char, as attorney-in-fact for Anthony Armenta


Represents a grant of restricted common stock to a corporation owned by the Reporting Person as compensation for the Reporting Person's past performance.


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock; vested RSUs are payable in the form of cash, shares of the Issuer's common stock or a combination thereof, except as otherwise indicated below. To the extent vested RSUs are paid in shares of the Issuer's common stock, such shares will be delivered to the reporting person as soon as possible after vesting, but in no event later than two and one-half months after the end of the year in which vesting occurs, subject to the collection of withholding taxes. Dividend equivalent rights accrue with respect to unvested RSUs in the form of additional RSUs ("Dividend Units") when and as dividends are paid on the Issuer's common stock, and Dividend Units vest on the same dates and in the same relative proportions as the RSUs on which they accrue.

The RSUs vest in four equal annual installments beginning on August 4, 2026.

Delia J. Makhlouta, by power of attorney


The price reported in column 4 is a weighted average price. The shares are sold in multiple transactions at prices ranging from $179.71 to $181.335. The reporting person undertakes to provide Howmet Aerospace Inc. ("Howmet"), any security holder of Howmet, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

/s/ Margaret Lam, Assistant Secretary (Attorney-in-Fact)


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock; vested RSUs are payable in the form of cash, shares of the Issuer's common stock or a combination thereof, except as otherwise indicated below. To the extent vested RSUs are paid in shares of the Issuer's common stock, such shares will be delivered to the reporting person as soon as possible after
vesting, but in no event later than two and one-half months after the end of the year in which vesting occurs, subject to the collection of withholding taxes. Dividend equivalent rights accrue with respect to unvested RSUs in the form of additional RSUs ("Dividend Units") when and as dividends are paid on the Issuer's common stock, and Dividend Units vest on the same dates and in the same relative proportions as the RSUs
on which they accrue.

Executive Vice President and Chief Strategy and Business Transformation Officer


Mr. Pruitt disclaims beneficial ownership of the securities indicated, and the reporting herein of such securities, shall not be construed as an admission that the undersigned is the beneficial owner thereof for
purposes of Section 16 or for any other purpose.

Mr. Pruitt is the President of Pruitt Ventures, Inc. which is the general partner of Pruitt Enterprises, LP and has voting and dispositive power with respect to these shares. Mr. Pruitt disclaims beneficial ownership except to the extent of any indirect pecuniary interest therein.


Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for consulting services, which vest in three equal monthly amounts at the rate of 20,000 Shares at the end of each month of service.


Common Stock

The option was granted on November 3, 2023 and vests in five (5) equal annual installments. The first installment vested on November 3, 2024 and the next four installments will vest on October 7, 2025, 2026, 2027 and 2028.


Shares were sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on December 2, 2024.

The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $33.44 to $33.95, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.


The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Represents the weighted average sales price per share. The shares sold at prices ranging from $1.42 to $1.4759 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

By the K-A Family Trust dated December 6, 2021

Class A Common Stock

Class A Common Stock

Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.80 to $114.79. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.80 to $115.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.88 to $111.87. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.88 to $112.87. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.88 to $113.87. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.88 to $114.08. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The Class B common stock is convertible into an equal number of shares of Class A common stock at any time, at the holder's election. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers, or upon the occurrence of certain specified events, in each case as set forth in the Issuer's Amended and Restated Certificate of Incorporation.


Restricted stock units ("RSUs") granted pursuant to the American Public Education, Inc. 2017 Omnibus Incentive Plan, as amended. The RSUs vest in three equal annual installments commencing on the first anniversary of the grant date.

/s/ Richard W. Sunderland, Jr., Attorney-in-Fact


These shares were retained by the Issuer in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of the restricted stock units. The amount retained by the Issuer was not in excess of the amount of the tax liability.

The total beneficial ownership of shares includes 446 shares acquired on June 30, 2025 under the Issuer's 2012 Employee Stock Purchase Plan.

/s/ Tracy Feanny, Attorney in Fact For: Erhaan Shaikh


The transaction was executed in multiple trades at prices ranging from $61.28 to $62.27 The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.

The transaction was executed in multiple trades at prices ranging from $62.28 to $62.61 The price above reflects the weighted average sales price. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.

Held by the Hagedorn Partnership, L.P. (the "Hagedorn Partnership"). James Hagedorn, Katherine Hagedorn Littlefield, Peter Hagedorn, Robert Hagedorn, and Susan Hagedorn are the general partners of the Hagedorn Partnership. Each of the general partners disclaim beneficial ownership of the reported securities, except to the extent of their pecuniary interest therein.

Held directly by James Hagedorn.

Held indirectly by a 401(K) plan for James Hagedorn. Mr. Hagedorn is Chairman, Chief Executive Officer and President of the Issuer.

Held directly by Katherine Hagedorn Littlefield.

Held directly by Nathan Baxter. Mr. Baxter is Executive Vice President and Chief Operating Officer of the Issuer.


Class A Common Stock

Class A Common Stock

Class A Common Stock

Shares of Class V-1 Common Stock of the Issuer have no economic rights and each share of Class V-1 Common Stock entitles its holder to 1 vote per share.

The term "Symbotic Holdings Units" is used herein to represent limited liability company units of Symbotic Holdings LLC ("Symbotic Holdings") and an equal number of paired shares of Class V-1 Common Stock of the Issuer, which, pursuant to the limited liability company agreement of Symbotic Holdings, are redeemable by the holder on a one-for-one basis for a share of Class A Common Stock of the Issuer, subject to conversion rate adjustments for stock splits, stock dividends, reclassification and other similar transactions, and in accordance with other terms and conditions set forth in Symbotic Holdings' Second Amended and Restated Limited Liability Company Agreement, dated as of June 7, 2022. Upon redemption, the Issuer will cancel the Symbotic Holdings Units and cancel and retire for no consideration the redeemed shares of Class V-1 Common Stock.

On August 4, 2025, the Reporting Person sold 4,000 shares of Class A Common Stock pursuant to a trading plan entered into by the Reporting Person on February 19, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Stock Sale").  In connection with the Stock Sale and pursuant to the terms of the trading plan, effective August 4, 2025, the Reporting Person redeemed 4,000 Symbotic Holdings Units in exchange for an equal number of shares of Class A Common Stock (the "Redemption"). In connection with the Redemption, Symbotic Holdings canceled the Symbotic Holdings Units, and the Issuer canceled and retired for no consideration the redeemed 4,000 shares of Class V-1 Common Stock.

Todd Krasnow may be considered the beneficial owner of securities held by Inlet View, Inc., of which Mr. Krasnow is the President and CEO. Mr. Krasnow disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

This transaction was executed pursuant to a trading plan entered into by the Reporting Person on February 19, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $51.685 to $52.60, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $52.74 to $53.615, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $53.75 to $54.745, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $54.765 to $55.715, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $55.77 to $56.54, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Todd Krasnow may be considered the beneficial owner of 25,000 shares of Class A Common Stock held by the Krasnow Family 2019 Charitable Remainder Trust and 25,000 shares of Class A Common Stock held by the Todd and Deborah Krasnow CRUT, both of which are trusts for which Mr. Krasnow is trustee and to which Mr. Krasnow is a beneficiary. Mr. Krasnow disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Consists of (i) 30,000 Symbotic Holdings Units and an equal number of paired shares of Class V-1 common stock held by the Reporting Person's spouse and (ii) 150,000 Symbotic Holdings Units and an equal number of paired shares of Class V-1 common stock held by the Todd J. Krasnow 2024 Irrevocable Trust, in which the Reporting Person's spouse acts as trustee and to which members of the Reporting Person's immediate family have a pecuniary interest.

The Reporting Person disclaims beneficial ownership of the securities held by his spouse.  The Reporting Person does not have voting or investment control over the securities held by the Todd J. Krasnow 2024 Irrevocable Trust and disclaims beneficial ownership of such securities except to the extent that the Reporting Person may be considered to have an indirect pecuniary interest therein.  This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the spouse's securities or the securities held by the trust for purposes of Section 16 or for any other purpose.

/s/ Corey Dufresne, Attorney-in-Fact for Todd Krasnow


These shares were retained by the Issuer in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of the restricted stock units. The amount retained by the Issuer was not in excess of the amount of the tax liability.

The total beneficial ownership of shares includes 446 shares acquired on June 30, 2025 under the Issuer's 2012 Employee Stock Purchase Plan.

/s/ Tracy Feanny, Attorney in Fact For: Tonya Stevens


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.

The transaction was executed in multiple trades at prices ranging from $271.4200 to $272.3500. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $272.4250 to $273.3700. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $273.4500 to $274.2400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $271.1350 to $271.1725. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $261.0700 to $262.0000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $262.2600 to $262.7100. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The shares are held in grantor retained annuity trusts for the benefit of the reporting person and his children. The reporting person serves as trustee of the grantor retained annuity trusts.

The shares are held in trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts.

/s/ Kathleen Peacock, by power of attorney


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.55 to $195.55, inclusive. The Reporting Person undertakes to provide to any security holder of Alphabet Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to (3) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.56 to $196.56, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.56 to $197.56, inclusive.

Class C GSUs entitle the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the GSU as GSU vests. 1/12th of the GSU vested on March 25, 2023 and an additional 1/12th of the GSU vests quarterly thereafter until the GSUs are fully vested, subject to continuing employment on the applicable vesting dates.

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 2, 2024.

s/ Valentina Margulis, as Attorney-in-Fact for Sundar Pichai


Represents shares of the Issuer's common stock sold to satisfy tax withholding obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs pursuant to provisions of a restricted stock unit agreement by and between the Issuer and the Reporting Person.

/s/ Jongmin Char, as attorney-in-fact for Evan Dunn


/s/ Jongmin Char, as attorney-in-fact for Brian Read


Class A Common Stock

Class A Common Stock

The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will convert automatically into shares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (a) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions, (b) the death or incapacity of Mr. Skates, (c) the date that is six months following the date on which Mr. Skates is no longer an employee or director of the Issuer (unless Mr. Skates has rejoined the Issuer during such six-month period) or (d) the date that is six months following the date on which none of the Issuer's founders is an employee or director of the Issuer (unless a founder has rejoined the Issuer during such six-month period).

This transaction involved a gift of securities by the reporting person to his wife. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

/s/ Elizabeth Fisher, as attorney in fact for Spenser Skates


/s/ Jongmin Char, as attorney-in-fact for Euan Abraham


Coller Secondaries Private Equity Opportunities Fund

Schnurman Josh

C/O COLLER PRIV MKT SECONDARIES ADVISORS

Purchase as of 7/1/2025 for which NAV pricing was finalized on 7/24/2025.


Common Stock

The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

Approximately 26% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 74% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.


/s/ Jongmin Char, as attorney-in-fact for Touraj Parang


Common Stock

Approximately 30% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020 and approximately 70% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.


/s/ Jongmin Char, as attorney-in-fact for Ali Kashani


The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

This transaction was executed in multiple trades at prices ranging from $17.36 USD to $17.39 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 11,124 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Reflects the transfer of shares from the Reporting Person to The Jeffrey W. Dunn Living Trust dated May 17, 2012.

Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.

/s/ Michael A. Pisetsky, Attorney-in-Fact for Jeffrey W. Dunn


Includes an aggregate of 62,311 shares of common stock issuable pursuant to previously reported restricted stock units and performance-based restricted stock units that have not vested. These unvested units include 45,722 restricted stock units that vest over time, and 16,589 performance-based restricted stock units that vest based on certain absolute and relative price performance of the issuer's common stock over various performance periods.


The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $75.29 to to $76.27.  The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each specific price within the range reported.

The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $776.29 to to $76.31.  The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.

/s/ Amanda J. Skov, Attorney-in-Fact for David J. Morehouse


Shares sold pursuant to a 10b5-1 Trading Plan dated December 12, 2025, entered into for personal tax and estate planning purposes.

The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $73.87 to to $74.86.  The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each specific price within the range reported.

The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $74.87 to to $75.86.  The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.

The price reported is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $75.87 to to $76.33.  The reporting person undertakes to provide to the Issuer, its security holders and the Staff of the SEC, upon request, full information regarding the number of shares sold at each specific price within the range reported.

/s/ Amanda J. Skov, Attorney-in-Fact for Robert S. Wetherbee


The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock awards. The sale was made to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.


Common Stock

Represents shares of common stock withheld by the Issuer pursuant to the terms of the award to pay tax withholding obligations of the Reporting Person upon the vesting of the restricted stock units.

Held of record by the Kenneth M. Young Revocable Trust U/A 5/8/15.

Each restricted stock unit (RSU) is granted pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated Long-Term 2021 Incentive Plan and represents a contingent right to receive one share of BW common stock.

RSUs vest in three annual installments beginning August 5, 2025.

/s/ John J. Dziewisz, attorney-in-fact for Kenneth M. Young


The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.

s/ Ronald J. Masciantonio, as Attorney-In-Fact for Thomas M. Ryan


Common Stock

The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $157.78 to $157.90 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.


Common Stock

The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.13. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The stock options are fully vested.


On May 30, 2025, the Reporting Person transferred 1,834 shares of Class A Common Stock previously held directly to the Andrea L Wong Living Trust for which the Reporting Person serves as trustee. The Reporting Person is the sole beneficiary of the trust.

These shares are held directly by Andrea L Wong Living Trust.

A portion of these securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

/s/ Mark Reinstra Attorney-in-Fact for Andrea L Wong


Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunities Fund, L.P., and Silver Point Distressed Opportunity Institutional Partners, L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by Funds except to the extent of their pecuniary interests.


Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit is the economic equivalent of one share of JKHY common stock and represents a contingent right to receive one share of JKHY common stock or, at the Issuer's option, the cash value thereof.

On August 4, 2022 the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2023, 2024 and 2025.

On August 4, 2023 the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2024, 2025 and 2026.

On August 4, 2024 the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2025, 2026 and 2027.

On August 4, 2025 the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2026, 2027 and 2028.

Andrew Potter By Power of Attorney For Gregory R. Adelson


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The reporting person has elected to defer settlement of 708 restricted stock units, which have fully vested and will become payable, in cash or common stock, at the Issuer's option, upon the reporting person's termination of employment or on specified future dates, pursuant to the reporting person's elections under the Issuer's Deferred Compensation Plan. Each vested restricted stock unit is the economic equivalent of one share of JKHY common stock.

Andrew Potter By Power of Attorney For Craig Keith Morgan


Common Stock

Common Stock

Common Stock

Common Stock

Andrew Potter By Power of Attorney For Renee A. Swearingen


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

On August 4, 2022, the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2023, 2024 and 2025.

On August 4, 2023, the reporting person was granted restricted stock units, vesting in three equal annual installments on August 4, 2024, 2025 and 2026.

The reporting person has elected to defer settlement of 1,202 restricted stock units, which have fully vested and will become payable, in cash or common stock, at the Issuer's option, upon the reporting person's termination of employment or on specified future dates, pursuant to the reporting person's elections under the Issuer's Deferred Compensation Plan. Each vested restricted stock unit is the economic equivalent of one share of JKHY common stock.

Andrew W. Potter by Power of Attorney For Mimi L. Carsley


Common Stock

Common Stock

Common Stock

Common Stock

Andrew Potter by Power of Attorney for Shanon G. McLachlan


Common Stock

Common Stock

Common Stock

On August 4, 2024 the reporting person was granted restricted stock units, vesting in full on August 4, 2025.

Andrew Potter By Power of Attorney For David B. Foss


Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated June 9, 2023.

Represents the Reporting Person's pro rata portion of the total shares sold on the transaction date to cover taxes upon the vesting of restricted stock units for certain employees of the Issuer.

The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of restricted stock units for certain
employees of the Issuer. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of
the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Cara Schembri as Attorney in-fact for Siddharth Thacker


/s/ Cara Schembri as Attorney in-fact for Andrew Rau


Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated December 22, 2021

Represents the Reporting Person's pro rata portion of the total shares sold on the transaction date to cover taxes upon the vesting of restricted stock units for certain employees of the Issuer

/s/ Cara Schembri as Attorney-in-fact for Sarah K. Tam


Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated December 22, 2021.


Common Stock

Includes shares of restricted stock which vest at a rate of 20% per year commencing on August 26, 2023.

Stock options vest at a rate of 20% per year commencing on August 26, 2023.

/s/ Kelly Pecoraro, pursuant to Power of Attorney


Shares sold to diversify retirement assets.


Class A Common Stock

Class A Common Stock

Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.

Subject to continued service, the restricted stock units vest in substantially equal installments on each of the first four anniversaries of the grant date, with vesting accelerated upon death, disability, or a change in control of the Issuer.  Upon vesting, the restricted stock units will be settled on the earliest of the termination of service, the fourth anniversary of the grant date, and a change in control of the Issuer, and will be settled in shares of the Issuer's Class A common stock or, at the discretion of the Issuer's Compensation Committee, cash (or a combination thereof).

Subject to continued service, the restricted stock units vest in four substantially equal installments on each of August 31, 2025; November 30, 2025; February 28, 2026; and May 31, 2026, with vesting accelerated upon death, disability, or a change in control of the Issuer.  Upon vesting, the restricted stock units will be settled on the earliest of the termination of service, the fifth anniversary of the grant date, and a change in control of the Issuer, and will be settled in shares of the Issuer's Class A common stock or, at the discretion of the Issuer's Compensation Committee, cash (or a combination thereof).

/s/ David K.F. Gillis, as Attorney-in-Fact


The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.

/s/ Ronald J. Masciantonio, as Attorney-In-Fact for Mimi Vaughn


/s/ Ronald J. Masciantonio, as Attorney-In-Fact for Richard L. Markee


The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of 31,250.00, less applicable tax withholdings.

/s/ Ronald J. Masciantonio, as Attorney-In-Fact for Dinesh Lathi


Shares sold pursuant to a pre-established 10b5-1(c) trading plan adopted on August 8, 2024.

This transaction was executed in multiple trades at prices ranging from $215.09 to $215.875. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $216.1 to $216.99. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/Catherine Gorecki by power of attorney filed 06/13/2024


The transactions were executed pursuant to a Rule 10b5-1 plan.

/s/ Jeffrey J. LaValle, under Power of Attorney  for Timothy J. Jahnke


The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $25,178.57, less applicable tax withholdings.

/s/ Ronald J. Masciantonio, as Attorney-In-Fact for Kathleen S. Barclay


This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 09/05/2024.

/s/ Joseph P. McDermott by Power of Attorney


TOCIO MARY ANN

C/O BRIGHT HORIZONS FAMILY SOLUTIONS INC

This transaction was executed in multiple trades at prices ranging from $120.04 to $120.205. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ John Casagrande, attorney-in-fact for Mary Ann Tocio


All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 5, 2025.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $158.47 to a high of $159.42, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $159.53 to a high of $160.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $160.49 to a high of $161.45, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $161.63 to a high of $162.41, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $162.71 to a high of $163.44, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.

Represents the weighted-average sale price per share of a series of transactions, all of which were executed on August 5, 2025. The actual sale prices ranged from a low of $163.50 to a high of $164.23, inclusive. The reporting person undertakes to provide upon request of the SEC staff, iRhythm Technologies, Inc. or any security holder of iRhythm Technologies, Inc., full information regarding the numbers of shares sold at each price within the range. The amount reflected has been rounded to 4 decimal points.


Class A Common Stock

Each phantom stock unit is the economic equivalent of one share of Class A Common Stock of Greif, Inc.

The phantom stock units are to be settled in cash upon the earlier of (i) a future fixed date designated by the Reporting Person made at the time of the deferral election, or (ii) the Reporting Person's termination from the Board due to his retirement, death, disability or other reason.

B. Andrew Rose by L. Dennis Hoffman, Jr. pursuant to a POA filed with the Commission.


Class A Common Stock

The reporting person was granted Restricted Stock Units representing contingent right to receive one share of Clearwater Analytics Holdings Inc. common stock for each RSU. The award will vest annually over 3 years on the anniversary of grant.

/s/ Alphonse Valbrune, as Attorney-in-Fact, for Bas NieuweWeme


Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on April 15, 2022 to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").

Represents "sell to cover" sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person's spouse on April 15, 2022 to cover tax withholding obligations in connection with the vesting of RSUs.

Represents performance-based restricted stock units ("PRSUs") granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on January 18, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2023 fiscal year by the Compensation Committee of the Board of Directors. On March 22, 2024, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person on January 18, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 33.33% of these RSUs will vest on February 1, 2026, and 33.33% will vest each six-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents PRSUs granted to the filing person. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 4, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2024 fiscal year by the Compensation Committee of the Board of Directors. On March 26, 2025, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2027, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person on April 4, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 8% will vest on November 1, 2025, 20.38% will vest on December 1, 2025, and 8% will vest on February 1, 2026 and on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person on January 18, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 100% of these RSUs will vest on February 1, 2026, subject to the filing person's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person's spouse on April 7, 2022. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions and will vest on February 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.

Represents PRSUs granted to the filing person's spouse. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 6, 2023 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2023 fiscal year by the Compensation Committee of the Board of Directors. On March 22, 2024, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person's spouse on April 6, 2023 and June 26, 2023. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. With respect to 11,760 of the RSUs, 33.33% will vest on February 1, 2026, and 33.33% will vest each six-month anniversary thereafter, subject to the filing person's spouse continued employment with Chewy, Inc. through the applicable vesting date. With respect to 2,593 of the RSUs, 100% will vest on April 1, 2026, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.

Represents PRSUs granted to the filing person's spouse. Each PRSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The PRSUs were initially granted on April 4, 2024 and August 5, 2024 and the amount of PRSUs eligible for vesting was subject to certification of the satisfaction of certain performance conditions for the 2024 fiscal year by the Compensation Committee of the Board of Directors. On March 26, 2025, the Compensation Committee of the Board of Directors certified the achievement of the performance conditions for the PRSUs, which vest on February 1, 2027, subject to the filing person's spouse's continued employment with Chewy, Inc. through the vesting date.

Represents RSUs granted to the filing person's spouse on April 4, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 9.67% will vest on November 1, 2025, 3.30% will vest on December 1, 2025, and 9.67% will vest on February 1, 2026 and on each three-month anniversary thereafter, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person's spouse on April 8, 2025. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 25% of these RSUs will vest on March 1, 2026, and 6.25% will vest on each three-month anniversary thereafter, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.

Represents RSUs granted to the filing person's spouse on August 5, 2024. Each RSU represents a contingent right to receive one share of Class A common stock of Chewy, Inc. The RSUs are subject to time-vesting conditions. 2.83% of these RSUs will vest on November 1, 2025 and each three-month anniversary thereafter except for February 1, 2026, when 74.56% will vest, subject to the filing person's spouse's continued employment with Chewy, Inc. through the applicable vesting date.

/s/ Da-Wai Hu, as Attorney-in-Fact for Sumit Singh